United States Autoimmune Drugs Market Size, Share, Growth, and Industry Analysis, Type (Biologics, Small Molecules, Biosimilars), Application (Rheumatoid Arthritis, Lupus, Multiple Sclerosis), Regional Insights and Forecast to 2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: United States Autoimmune Drugs Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on United States Autoimmune Drugs Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. United States Autoimmune Drugs Market, Type
   1. Introduction
      1. Market Size and Forecast, Type
   2. Biologics
      1. Market Size and Forecast, By Region
   3. Small Molecules
      1. Market Size and Forecast, By Region
   4. Biosimilars
      1. Market Size and Forecast, By Region
10. United States Autoimmune Drugs Market, Application
    1. Introduction
       1. Market Size and Forecast, Application
    2. Rheumatoid Arthritis
       1. Market Size and Forecast, By Region
    3. Lupus
       1. Market Size and Forecast, By Region
    4. Multiple Sclerosis
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. U.S.
       1. Market Size and Forecast
          1. Type
             1. Biologics
             2. Small Molecules
             3. Biosimilars
          2. Application
             1. Rheumatoid Arthritis
             2. Lupus
             3. Multiple Sclerosis
12. Competitive Landscape, 2025
    1. Introduction
    2. United States Autoimmune Drugs Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. AbbVie Inc.
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Johnson & Johnson
    3. Pfizer Inc.
    4. Bristol-Myers Squibb
    5. Roche Holding AG
    6. Novartis AG
    7. Amgen Inc.
    8. Eli Lilly and Company
    9. Sanofi S.A.
    10. Biogen Inc.
    11. Regeneron Pharmaceuticals
    12. Gilead Sciences
    13. GlaxoSmithKline plc
    14. Takeda Pharmaceutical Company